Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julien Hanson

Showing results (31-40 of 67) with videos related to

Pageof 7
Sort By:
Cell Metabolism|April 9, 2010
An autocrine lactate loop mediates insulin-dependent inhibition of lipolysis through GPR81Kashan Ahmed, Sorin Tunaru, Cong Tang, et al.
European Journal of Medicinal Chemistry|May 22, 2013
Synthesis and pharmacological evaluation of 2-aryloxy/arylamino-5-cyanobenzenesulfonylureas as novel thromboxane A₂ receptor antagonistsSylvie-Mireille Bambi-Nyanguile, Julien Hanson, Annie Ooms, et al.
The Journal of Clinical Investigation|July 29, 2010
Nicotinic acid- and monomethyl fumarate-induced flushing involves GPR109A expressed by keratinocytes and COX-2-dependent prostanoid formation in miceJulien Hanson, Andreas Gille, Sabrina Zwykiel, et al.
European Journal of Medicinal Chemistry|August 28, 2021
Structure-activity relationships of agonists for the orphan G protein-coupled receptor GPR27Thanigaimalai Pillaiyar, Francesca Rosato, Monika Wozniak, et al.
Current Pharmaceutical Design|March 15, 2006
From the design to the clinical application of thromboxane modulatorsJean-Michel Dogné, Julien Hanson, Xavier de Leval, et al.
European Journal of Medicinal Chemistry|March 2, 2023
New insights in the development of positive allosteric modulators of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors belonging to 3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxides: Introduction of (mono/difluoro)methyl groups at the 2-position of the thiadiazine ringEric Goffin, Pierre Fraikin, Dayana Abboud, et al.
Cardiovascular Drug Reviews|May 4, 2005
Pharmacological profile and therapeutic potential of BM-573, a combined thromboxane receptor antagonist and synthase inhibitorAlexandre Ghuysen, Jean-Michel Dogné, Patrice Chiap, et al.
Journal of Cardiovascular Pharmacology|January 18, 2005
Effects of dobutamine on left ventriculoarterial coupling and mechanical efficiency in acutely ischemic pigsPhilippe Kolh, Bernard Lambermont, Alexandre Ghuysen, et al.
The Journal of Biological Chemistry|June 30, 2009
Deorphanization of GPR109B as a receptor for the beta-oxidation intermediate 3-OH-octanoic acid and its role in the regulation of lipolysisKashan Ahmed, Sorin Tunaru, Claus-Dieter Langhans, et al.
British Journal of Pharmacology|February 5, 2017
Identification and pharmacological characterization of succinate receptor agonistsPierre Geubelle, Julie Gilissen, Sébastien Dilly, et al.
Pageof 7

Showing results (31-40 of 67) with videos related to

Sort By:
Pageof 7
Cell Metabolism|April 9, 2010
An autocrine lactate loop mediates insulin-dependent inhibition of lipolysis through GPR81Kashan Ahmed, Sorin Tunaru, Cong Tang, et al.
European Journal of Medicinal Chemistry|May 22, 2013
Synthesis and pharmacological evaluation of 2-aryloxy/arylamino-5-cyanobenzenesulfonylureas as novel thromboxane A₂ receptor antagonistsSylvie-Mireille Bambi-Nyanguile, Julien Hanson, Annie Ooms, et al.
The Journal of Clinical Investigation|July 29, 2010
Nicotinic acid- and monomethyl fumarate-induced flushing involves GPR109A expressed by keratinocytes and COX-2-dependent prostanoid formation in miceJulien Hanson, Andreas Gille, Sabrina Zwykiel, et al.
European Journal of Medicinal Chemistry|August 28, 2021
Structure-activity relationships of agonists for the orphan G protein-coupled receptor GPR27Thanigaimalai Pillaiyar, Francesca Rosato, Monika Wozniak, et al.
Current Pharmaceutical Design|March 15, 2006
From the design to the clinical application of thromboxane modulatorsJean-Michel Dogné, Julien Hanson, Xavier de Leval, et al.
European Journal of Medicinal Chemistry|March 2, 2023
New insights in the development of positive allosteric modulators of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors belonging to 3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxides: Introduction of (mono/difluoro)methyl groups at the 2-position of the thiadiazine ringEric Goffin, Pierre Fraikin, Dayana Abboud, et al.
Cardiovascular Drug Reviews|May 4, 2005
Pharmacological profile and therapeutic potential of BM-573, a combined thromboxane receptor antagonist and synthase inhibitorAlexandre Ghuysen, Jean-Michel Dogné, Patrice Chiap, et al.
Journal of Cardiovascular Pharmacology|January 18, 2005
Effects of dobutamine on left ventriculoarterial coupling and mechanical efficiency in acutely ischemic pigsPhilippe Kolh, Bernard Lambermont, Alexandre Ghuysen, et al.
The Journal of Biological Chemistry|June 30, 2009
Deorphanization of GPR109B as a receptor for the beta-oxidation intermediate 3-OH-octanoic acid and its role in the regulation of lipolysisKashan Ahmed, Sorin Tunaru, Claus-Dieter Langhans, et al.
British Journal of Pharmacology|February 5, 2017
Identification and pharmacological characterization of succinate receptor agonistsPierre Geubelle, Julie Gilissen, Sébastien Dilly, et al.
Pageof 7